J. Basile

R. Townsend, K. Ferdinand, D. Kandzari, 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Ambulatory blood pressure monitoring to diagnose hypertension--an idea whose time has come.

J. Basile, M. Bloch, 2016, Journal of the American Society of Hypertension : JASH.

A novel kidney disease index reflecting both the albumin-to-creatinine ratio and estimated glomerular filtration rate, predicted cardiovascular and kidney outcomes in type 2 diabetes

G. Dagenais, D. Xavier, Lawrence A Leiter, 2022, Cardiovascular Diabetology.

Exposure to Air Pollution Increases the Incidence of Hypertension and Diabetes in Black Women Living in Los Angeles

J. Basile, M. Bloch, 2012, Journal of clinical hypertension.

Gaining weight increases the risk for the development of heart failure.

J. Basile, 2002, Journal of clinical hypertension.

Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial

M. Uder, A. Cremer, P. Gosse, 2021, The Lancet.

Effects of a calcium channel blocker and a statin-based treatment regimen in the Anglo-Scandinavian Cardiac Outcomes Trial.

J. Basile, M. Bloch, 2007, Journal of clinical hypertension.

Predictors of blood pressure response to ultrasound renal denervation in the RADIANCE-HTN SOLO study

P. Gosse, A. Kirtane, P. Blankestijn, 2021, Journal of Human Hypertension.

Getting to Goal Blood Pressure: Why Reserpine Deserves a Second Look

W. Cushman, A. Bertoni, R. Grimm, 2007, Journal of clinical hypertension.

Uncontrolled Hypertension in an Elderly Man on Multiple Antihypertensive Drugs.

A. Dominiczak, R. Touyz, J. Basile, 2020, Hypertension.

Chapter 46 – Hypertensive Emergencies and Urgencies

J. Basile, S. Rehman, W. Elliott, 2013 .

Analysis of Recent Papers in Hypertension Jan Basile, MD, Senior Editor

J. Basile, M. Bloch, 2004 .

12-Month Results From the Unblinded Phase of the RADIANCE-HTN SOLO Trial of Ultrasound Renal Denervation.

P. Gosse, A. Kirtane, R. Schmieder, 2020, JACC. Cardiovascular interventions.

Analysis of Recent Papers in Hypertension

J. Basile, M. Bloch, 2006, Journal of clinical hypertension.

NEW US GUIDELINES ON HIGH BLOOD PRESSURE IN CHILDREN AND ADOLESCENTS

J. Basile, M. Bloch, 2004 .

ANGIOTENSIN RECEPTOR BLOCKER COMPARED TO A β BLOCKER-BASED TREATMENT REGIMEN IN HYPERTENSIVE PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY: THE LIFE TRIAL In patients with hypertension, left ventricular hypertrophy (LVH) is a major independent risk

J. Basile, 2002 .

Determining the Relative Antihypertensive Potency and Relative Cardiovascular Risk Reduction Associated With Different Thiazide and Thiazide‐Type Diuretics

J. Basile, M. Bloch, 2013, Journal of clinical hypertension.

P-201: Treatment and control of hypertension in the veterans health administration

W. Cushman, P. Glassman, F. Cunningham, 2004 .

Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

B. Davis, P. Whelton, J. Cutler, 2006, Archives of internal medicine.

Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post‐hoc analysis from the REWIND randomized trial

G. Dagenais, P. Pais, Lawrence A Leiter, 2022, European journal of heart failure.

Analysis of Recent Papers in Hypertension

J. Basile, M. Bloch, 2006 .

2003 update on the Hypertension Initiative of South Carolina. Bringing South Carolina from "worst to first" in cardiovascular health.

D. Lackland, B. Egan, J. Basile, 2003, Journal of the South Carolina Medical Association.

Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial

Neil Chapman, Manish Saxena, Jai Radhakrishnan, 2018, The Lancet.

Addressing the global cardiovascular risk of hypertension, dyslipidemia, and insulin resistance in the southeastern United States.

D. Lackland, B. Egan, J. Basile, 2005, The American journal of the medical sciences.

Baseline Characteristics of Participants in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

W. Cushman, M. Proschan, K. Margolis, 2001, Hypertension.

Combination Therapy in Hypertension

G. Bakris, J. Basile, A. Gradman, 2011, Journal of clinical hypertension.

ASH Position Article Combination therapy in hypertension

G. Bakris, J. Basile, A. Gradman, 2010 .

Combination therapy in hypertension.

G. Bakris, J. Basile, A. Gradman, 2010, Journal of the American Society of Hypertension : JASH.

Analysis of Recent Papers in Hypertension Initial Combination Therapy Provides More Prompt Blood Pressure Control and Reduces Cardiovascular Events But Remains Underutilized

J. Basile, M. Bloch, 2013, Journal of clinical hypertension.

Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial

D. Xavier, P. López-Jaramillo, Lawrence A Leiter, 2020, The Lancet Neurology.

Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study).

D. Goff, W. Cushman, E. Soliman, 2014, The American journal of cardiology.

Progression of kidney disease in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin versus usual care: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

B. Davis, Mahboob Rahman, J. Basile, 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

ORIGINAL INVESTIGATIONS Pathogenesis and Treatment of Kidney Disease Progression of Kidney Disease in Moderately Hypercholesterolemic, Hypertensive Patients Randomized to Pravastatin Versus Usual Care: A Report From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALL

B. Davis, Mahboob Rahman, J. Basile, 2008 .

Preliminary evaluation of phosphatidylethanol and alcohol consumption in patients with liver disease and hypertension.

P. Miller, J. Basile, P. Randall, 2009, Alcohol and alcoholism.

Critical appraisal of amlodipine and olmesartan medoxomil fixed-dose combination in achieving blood pressure goals

J. Basile, 2010, Integrated blood pressure control.

Combination therapy in hypertension.

S. Oparil, G. Bakris, H. Black, 2010, Journal of the American Society of Hypertension : JASH.

Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial

Rodica Pop-Busui, Faramarz Ismail-Beigi, Robert Cuddihy, 2010, The Lancet.

The potential of sodium glucose cotransporter 2 (SGLT2) inhibitors to reduce cardiovascular risk in patients with type 2 diabetes (T2DM).

J. Basile, 2013, Journal of diabetes and its complications.

ASSESSMENT AND DETECTION Preliminary Evaluation of Phosphatidylethanol and Alcohol Consumption in Patients with Liver Disease and Hypertension

P. Miller, J. Basile, P. Randall, 2009 .

Addressing the Global Cardiovascular Risk of Hypertension, Dyslipidemia, Diabetes Mellitus, and the Metabolic Syndrome in the Southeastern United States, Part II: Treatment Recommendations for Management of the Global Cardiovascular Risk of Hypertension, Dyslipidemia, Diabetes Mellitus, and the Meta

D. Lackland, B. Egan, J. Basile, 2005, The American journal of the medical sciences.

Influence of metabolic syndrome and race on the relationship between intensive blood pressure control and cardiovascular outcomes in the SPRINT cohort

N. Kressin, L. Tamariz, T. Craven, 2018, Diabetes, obesity & metabolism.

A historical look at hypertension: celebrating 100 years with the Southern Medical Association.

J. Basile, H. Ventura, 2006, Southern medical journal.

Self-Measured Blood Pressure Monitoring at Home: A Joint Policy Statement From the American Heart Association and American Medical Association

J. Basile, K. Margolis, D. Shimbo, 2020, Circulation.

Halting the progression of heart failure: finding the optimal combination therapy.

J. Basile, 2002, Cleveland Clinic journal of medicine.

Meta‐Analysis Concludes Angiotensin Receptor Blocker Use Increases the Risk of Developing Cancer: Concerns About the Science and the Message

J. Basile, M. Bloch, 2010, Journal of clinical hypertension.

Antihypertensive therapy, new-onset diabetes, and cardiovascular disease

J. Basile, J. N. Basile, Ralph H Johnson, 2009, International journal of clinical practice.

National Utilization of Antihypertensive Medications From 2000 to 2006 in the Veterans Health Administration: Focus on Thiazide Diuretics

W. Cushman, D. Berlowitz, P. Glassman, 2008, Journal of clinical hypertension.

Hypertension and dementia: Does blood pressure control favorably affect cognition?

J. Basile, E. Majeski, C. Widener, 2004, Current hypertension reports.

Consortium for Southeastern Hypertension Control: Managing Hypertension in the Southeastern United States: Applying the Guidelines from the Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI)

W. Cushman, G. Mensah, E. Roccella, 1999 .

Managing hypertension in the southeastern United States: applying the guidelines from the Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI).

Daniel W. Jones, W. Cushman, G. Mensah, 1999, The American journal of the medical sciences.

Efficacy and safety of combination therapy with niacin extended-release and simvastatin versus atorvastatin in patients with dyslipidemia: The SUPREME Study.

J. Basile, W. Insull, P. Jiang, 2009, Journal of clinical lipidology.

Blood Pressure Control by Drug Group in the Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

B. Davis, P. Whelton, W. Cushman, 2008, Journal of clinical hypertension.

Baseline characteristics of the diabetic participants in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

B. Davis, J. Basile, D. Goff, 2001, Diabetes care.

Mortality and Morbidity During and After the Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial

B. Davis, P. Whelton, S. Oparil, 2012, Journal of clinical hypertension.

A Statewide Primary Care Approach to Cardiovascular Risk Factor Control in High‐Risk Diabetic and Nondiabetic Patients With Hypertension

D. Lackland, B. Egan, J. Basile, 2004, Journal of clinical hypertension.

Overcoming clinical inertia to achieve blood pressure goals: the role of fixed-dose combination therapy

J. Basile, J. Neutel, 2010, Therapeutic advances in cardiovascular disease.

Lessons learned from the ONTARGET and TRANSCEND trials

J. Basile, 2009, Current atherosclerosis reports.

COMBINATION THERAPY WITH THE ANGIOTENSIN-CONVERTING ENZYME INHIBITOR RAMIPRIL AND THE ANGIOTENSIN RECEPTOR BLOCKER TELMISARTAN FAILS TO REDUCE RENAL EVENTS IN PATIENTS AT HIGH RISK FOR CORONARY HEART DISEASE: THE ONTARGET STUDY

J. Basile, M. Bloch, 2008 .

Alcohol biomarker screening in medical and surgical settings.

P. Miller, B. Egan, J. Basile, 2006, Alcoholism, clinical and experimental research.

Chapter 39 – Hypertension in Older Patients

J. Basile, M. Bloch, 2013 .

The importance of systolic blood pressure control and cardiovascular disease prevention

J. Basile, 2003, Current treatment options in cardiovascular medicine.

Chapter 45 – Hypertensive Emergencies and Urgencies

J. Basile, S. Rehman, D. Vidt, 2007 .

UK Guidelines Call for Routine 24‐Hour Ambulatory Blood Pressure Monitoring in All Patients to Make the Diagnosis of Hypertension—Not Ready for Prime Time in the United States

J. Basile, M. Bloch, 2011, Journal of clinical hypertension.

Management of Global Risk Across the Continuum of Hypertensive Heart Disease

J. Basile, 2006, Journal of clinical hypertension.

Cardiovascular Risk Factor Control in Communities—Update From the ASH Carolinas‐Georgia Chapter, the Hypertension Initiative, and the Community Physicians' Network

D. Lackland, B. Egan, J. Basile, 2006, Journal of clinical hypertension.

Rationale for Fixed-Dose Combination Therapy to Reach Lower Blood Pressure Goals

J. Basile, 2008, Southern medical journal.

Review: The role of noninvasive hemodynamic monitoring in the evaluation and treatment of hypertension

Edward Frohlich, D. Lackland, J. Basile, 2007, Therapeutic advances in cardiovascular disease.

Fixed-dose combination therapy in the treatment of hypertension: ready for prime time.

J. Basile, 2007, Southern medical journal.

Achieving Blood Pressure Goals: Why Aren't We?

W. Cushman, J. Basile, 2006, Journal of clinical hypertension.

Comparison of Aliskiren/Hydrochlorothiazide Combination Therapy With Hydrochlorothiazide Monotherapy in Older Patients With Stage 2 Systolic Hypertension: Results of the ACTION Study

J. Basile, J. Botha, R. Weitzman, 2011, Journal of clinical hypertension.

Chapter 38 – Hypertension in the Elderly

J. Basile, M. Bloch, 2007 .

Hypertension in the Elderly: A Review of the Importance of Systolic Blood Pressure Elevation

J. Basile, 2002, Journal of clinical hypertension.

Hypertension in the elderly: recent developments and insights.

J. Basile, Hillel Sternlicht, 2020, Current opinion in cardiology.

How We Got Where We Are in Blood Pressure Targets

T. Fülöp, J. Basile, K. Soliman, 2021, Current Hypertension Reports.

Outcomes in adults with systolic blood pressure between 130 and 139 mmHg in Action to Control Cardiovascular Risk in Diabetes Blood Pressure trial and Systolic Blood Pressure Intervention Trial.

M. Rocco, W. Cushman, L. Tamariz, 2020, Journal of hypertension.

Cardiovascular Outcomes According to Systolic Blood Pressure in Patients With and Without Diabetes: An ACCOMPLISH Substudy

G. Bakris, B. Pitt, T. Hua, 2016, Journal of clinical hypertension.

Characteristics and Long-Term Follow-Up of Participants with Peripheral Arterial Disease During ALLHAT

B. Davis, P. Whelton, Mahboob Rahman, 2014, Journal of General Internal Medicine.

Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study

Wei Chen, J. Basile, T. Giles, 2014, The Lancet.

Identifying and Managing Factors that Interfere with or Worsen Blood Pressure Control

J. Basile, M. Bloch, 2010, Postgraduate medicine.

Renal Sympathetic Denervation for Blood Pressure Control: A Review of the Current Evidence and Ongoing Studies

M. Zile, J. Basile, T. Todoran, 2014, Journal of clinical hypertension.

New Therapeutic Options in Patients Prone to Hypertension: A Focus on Direct Renin Inhibition and Aldosterone Blockade

J. Basile, 2009, The American journal of the medical sciences.

The importance of early antihypertensive efficacy: the role of angiotensin II receptor blocker therapy

J. Basile, S. Chrysant, 2006, Journal of Human Hypertension.

Reference Section a Report by Controlling Blood Pressure in 50% of All Hypertensive Patients – an Achievable Goal in the Healthy People 2010 Report?

B. Egan, J. Basile, Ralph H Johnson, 2004 .

The Importance of Prompt Blood Pressure Control

J. Basile, 2008, Journal of clinical hypertension.

Incremental Risk‐Factor Reduction Improves Overall Cardiovascular Benefit: Is It Time to Abandon the Silos?

J. Basile, C. Ferrario, M. Houston, 2006, Journal of clinical hypertension.

A Multifactorial Approach to Reduce Cardiovascular Disease in Type 2 Diabetes Mellitus: Now More Than Ever

J. Basile, 2016, Hospital practice.

Prehypertension, racial prevalence and its association with risk factors: Analysis of the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.

V. Howard, D. Lackland, G. Howard, 2011, American journal of hypertension.

Does prehypertension represent an increased risk for incident hypertension and adverse cardiovascular outcome?

D. Lackland, S. Glasser, J. Basile, 2009, Hypertension.

Blood pressure responder rates versus goal rates: which metric matters?

J. Basile, 2009, Therapeutic advances in cardiovascular disease.

Risk of Hospitalization for Cardiovascular Events with β-Blockers in Hypertensive Patients: A Retrospective Cohort Study

B. Egan, J. Basile, J. Neutel, 2018, Cardiology and Therapy.

Spironolactone is More Effective Than Eplerenone at Lowering Blood Pressure in Patients With Primary Aldosteronism

J. Basile, M. Bloch, 2011, Journal of clinical hypertension.

A New Approach to Glucose Control in Type 2 Diabetes: The Role of Kidney Sodium-Glucose Co-transporter 2 Inhibition

J. Basile, 2011, Postgraduate medicine.

Total cardiovascular or fatal events in people with type 2 diabetes and cardiovascular risk factors treated with dulaglutide in the REWIND trail: a post hoc analysis

G. Dagenais, P. Pais, P. López-Jaramillo, 2020, Cardiovascular Diabetology.

General versus central adiposity as risk factors for cardiovascular-related outcomes in a high-risk population with type 2 diabetes: a post hoc analysis of the REWIND trial

P. Pais, H. Gerstein, J. Basile, 2023, Cardiovascular Diabetology.

Systolic blood pressure

J. Basile, Jan N Basile, 2002, BMJ : British Medical Journal.

American Society of Hypertension regional chapters: leveraging the impact of the clinical hypertension specialist in the local community.

D. Lackland, B. Egan, J. Basile, 2002, American journal of hypertension.

2011 Recommendations for the Diagnosis and Management of Gout and Hyperuricemia

A. H. Morton, T. C. Adamson, J. Basile, 2011, The Physician and sportsmedicine.

Endovascular Ultrasound Renal Denervation to Treat Hypertension: The RADIANCE II Randomized Clinical Trial.

Raghava R. Gollapudi, A. Cremer, S. Padmanabhan, 2023, JAMA.

Patient-Level Pooled Analysis of Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO Trials

P. Gosse, J. Basile, A. Kirtane, 2023, JAMA cardiology.

Treating the Black Hypertensive in 2010: Achieve Lower Targets While Awaiting More Definitive Evidence

J. Basile, M. Bloch, 2011, Journal of clinical hypertension.

What If Chlorthalidone-Associated Hyperglycemia Develops?—Reply

B. Davis, P. Whelton, J. Cutler, 2007 .

Highly Interactive Multi‐Session Programs Impact Physician Behavior on Hypertension Management: Outcomes of a New CME Model

J. Basile, Benjamin Whitfield, K. Merlo, 2011, Journal of clinical hypertension.

Clinical Inertia and Blood Pressure Goal Attainment

J. Basile, 2009 .

OR 70: Blood pressure control by randomized drug group in allhat

B. Davis, W. Cushman, J. Basile, 2004 .

Recognizing the Link Between CKD and CVD in the Primary Care Setting: Accurate and Early Diagnosis for Timely and Appropriate Intervention

J. Basile, 2007, Southern medical journal.

The Role of Therapeutic Inertia and the Use of Fixed‐Dose Combination Therapy in the Management of Hypertension

H. Black, J. Izzo, J. Basile, 2007, Journal of clinical hypertension.

and Adverse Cardiovascular Outcome? Does Prehypertension Represent an Increased Risk for Incident Hypertension

D. Lackland, S. Glasser, J. Basile, 2012 .

Analysis of Recent Papers in Hypertension  Jan Basile, MD, Senior Editor

J. Basile, M. Bloch, 2005 .

Systolic Blood Pressure Elevation

J. Basile, 2003, Drugs & aging.

Impact of Highly Interactive Multi-Session Educational Activities on Physician Behavior in Hypertension Management

J. Basile, Benjamin Whitfield, K. Merlo, 2011 .

Effects of intensive blood-pressure control in type 2 diabetes mellitus.

J. Cutler, W. Cushman, J. Bigger, 2010, The New England journal of medicine.

Combination Therapy in Hypertension

G. Bakris, J. Basile, A. Gradman, 2011, Journal of clinical hypertension.

Renin-angiotensin-aldosterone system blockade in high-risk hypertensive patients: current approaches and future trends.

J. Basile, M. Bloch, Nageshwara Gullapalli, 2010, Therapeutic Advances in Cardiovascular Disease.

Metastatic gastroesophageal adenocarcinoma to skeletal muscle: a unique event.

J. Basile, S. Rehman, D. Cope, 2002, Southern medical journal (Birmingham, Ala. Print).

Design and baseline characteristics of participants in the Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) trial on the cardiovascular effects of dulaglutide

G. Dagenais, D. Xavier, P. Pais, 2018, Diabetes, obesity and metabolism.

Treating hypertension in the oldest of the old reduces total mortality: results of the Hypertension in the Very Elderly Trial (HYVET).

J. Basile, M. Bloch, 2008, The Journal of Clinical Hypertension.

Effects of Intensive BP Control in CKD.

P. Whelton, K. Sink, M. Rocco, 2017, Journal of the American Society of Nephrology : JASN.

Critical appraisal of amlodipine and olmesartan medoxomil fixed-dose combination in achieving blood pressure goals

J. Basile, 2010, Integrated blood pressure control.

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.

W. E. Sanabria, John A. Hamling, Ju Han Kim, 2019, Lancet.

FIRST-LINE ALISKIREN/HYDROCHLOROTHIAZIDE COMBINATION THERAPY LOWERS BLOOD PRESSURE MORE EFFECTIVELY THAN HYDROCHLOROTHIAZIDE ALONE IN OBESE OLDER PATIENTS WITH STAGE 2 HYPERTENSION: PP.34.376

J. Basile, R. Weitzman, M. Lillestol, 2010 .

Controlling Blood Pressure in 50% of All Hypertensive Patients: An Achievable Goal in the Healthy People 2010 Report?

B. Egan, J. Basile, 2003, Journal of Investigative Medicine.

Analysis of Recent Papers in Hypertension Jan Basile, MD, Senior Editor

J. Basile, M. Bloch, 2008 .

Combination therapy in hypertension.

G. Bakris, J. Basile, A. Gradman, 2010, Journal of the American Society of Hypertension : JASH.

Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

J. Cutler, W. Cushman, K. Peterson, 2007, The American journal of cardiology.

Orthostatic Hypotension in the ACCORD (Action to Control Cardiovascular Risk in Diabetes) Blood Pressure Trial: Prevalence, Incidence, and Prognostic Significance

J. Cutler, W. Cushman, J. Bigger, 2016, Hypertension.

The role of nitric oxide in improving endothelial function and cardiovascular health: focus on nebivolol.

G. Bakris, J. Basile, T. Giles, 2010, The American journal of medicine.

B. Davis, Mahboob Rahman, J. Basile, 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Analysis of Recent Papers in Hypertension

J. Basile, 2004 .

A Multifactorial Approach to Reduce Cardiovascular Disease in Type 2 Diabetes Mellitus: Now More Than Ever

J. Basile, 2016, Hospital practice.

Novel Indices of Cognitive Impairment and Incident Cardiovascular Outcomes in the REWIND Trial.

G. Dagenais, P. López-Jaramillo, Lawrence A Leiter, 2022, The Journal of clinical endocrinology and metabolism.

Analysis of Recent Papers in Hypertension

J. Basile, 1999, Journal of clinical hypertension.

One size does not fit all: the role of vasodilating beta-blockers in controlling hypertension as a means of reducing cardiovascular and stroke risk.

J. Basile, 2010, The American journal of medicine.

Treating the cardiometabolic syndrome: an opportunity to provide comprehensive cardiovascular risk reduction.

J. Basile, C. Ferrario, M. Houston, 2006, Journal of the cardiometabolic syndrome.